reglab/statecodes huggingface dataset:
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0030 - Licensure: Application

Current through Register Vol. 63, No. 7, July 1, 2024
(1) An application
			 for licensure as a Pharmacist may be accessed on the board website.
(2) The board may issue a license to a
			 qualified applicant after the receipt of:
(a)
			 Evidence of compliance with OAR
			 855-115-0020 or
			 855-115-0025;
(b) A completed application including:
(A) Payment of the fee prescribed in OAR
			 855-110;
(B) A current, passport
			 regulation size photograph (full front, head to shoulders);
(C) Personal identification or proof of
			 identity; and
(D) Certificate of
			 completion for the one hour of continuing pharmacy education in pain
			 management, provided by the Pain Management Commission of the Oregon Health
			 Authority;
(c) A
			 completed national fingerprint-based background check; and
(d) A completed moral turpitude statement or
			 a written description and documentation regarding all conduct that is required
			 to be disclosed.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0035 - Licensure: Renewal or Reinstatement

Current through Register Vol. 63, No. 7, July 1, 2024
(1) An applicant
			 for renewal of a Pharmacist license must:
(a)
			 Pay the biennial license fee required in OAR 855-110;
(b) Complete the continuing pharmacy
			 education requirements as outlined in OAR 855-135;
(c) Be subject to a criminal background
			 check; and
(d) Provide a written
			 description and documentation regarding all conduct that is required to be
			 disclosed.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0040 - Licensure: Lapse

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A Pharmacist
			 may let their license lapse by failing to renew or request that the board
			 accept the lapse of their license prior to the expiration date.
(a) Lapse of a license is not
			 discipline.
(b) The board has
			 jurisdiction to proceed with any investigation or any action or disciplinary
			 proceeding against the licensee.
(c) A person must not practice pharmacy if
			 their license is lapsed.
(d) A
			 person may apply for renewal or reinstatement of their license according to OAR
			 855-115-0035.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0045 - Licensure: Retire

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A Pharmacist
			 may request that the board retire their license if the Pharmacist is in good
			 standing, has been licensed as a Pharmacist for at least 20 years and is no
			 longer practicing pharmacy.
(a) A retired
			 license is not considered discipline.
(b) The board has continuing authority under
			 ORS 689.153.
(c) A person must not practice pharmacy if
			 the license is retired.
(d) A
			 person may apply for renewal or reinstatement according to OAR
			 855-115-0035.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0050 - Licensure: Voluntary Surrender

Current through Register Vol. 63, No. 7, July 1, 2024
A Pharmacist may request that the board accept the voluntary
				surrender of their license.
(1) A
			 voluntary surrender of a license is discipline.
(2) The license remains in effect until the
			 board accepts the surrender.
(3) If
			 the board accepts a request for voluntary surrender, the board will issue a
			 final order terminating the license, signed by the licensee and a board
			 representative. The termination date is the date the order is signed by all
			 parties and served on the licensee.
(4) The licensee must cease practicing
			 pharmacy from the date the license terminates.
(5) A voluntarily surrendered license cannot
			 be renewed. A former licensee who wants to obtain a license must apply for
			 reinstatement per OAR
			 855-115-0035 unless the final
			 order prohibits the licensee from doing so.
(6) The board has jurisdiction to proceed
			 with any investigation or any action or disciplinary proceeding against the
			 licensee.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.153
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0060 - Registration: In-State Volunteer

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A Pharmacist
			 may register with the board for the limitation on liability provided by ORS
			 676.340, which provides a
			 licensee with specific exemptions from liability for the provision of pharmacy
			 services without compensation under the terms of the law.
(2) A no cost registration may be issued by
			 the board upon receipt of a completed application. Registration requires
			 submission of a signed form provided by the board in accordance with ORS
			 676.345(2).
(3) Registration will expire at the
			 licensee's next license renewal date and may be renewed biennially. It is the
			 licensee's responsibility to ensure his or her active registration in this
			 program.
(4) Nothing in this
			 section relieves licensee from the responsibility to comply with board
			 regulations and still may be subject to disciplinary actions.
(5) Pharmacists providing care under the
			 provisions of ORS 676.340 and ORS
			 676.345 remain subject to the
			 board complaint investigation process articulated in ORS
			 676.175.
Statutory/Other Authority: ORS
				  676.340, ORS
				  689.205
Statutes/Other Implemented: ORS
				  676.340, ORS
				  676.345
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0065 - Notification: Out-of-State Volunteer

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A pharmacist
			 who is not licensed in Oregon may, without compensation and in connection with
			 a coordinating organization or other entity, practice pharmacy for 30 days each
			 calendar year. The pharmacist is not required to apply for licensure or other
			 authorization from the board to practice pharmacy under this section.
(2) To practice pharmacy under this section,
			 the pharmacist who is not licensed in Oregon must submit on a form prescribed
			 by the board, at least 10 days prior to commencing practice in this state, to
			 the board:
(a) Proof that the pharmacist is in
			 good standing and is not the subject of an active disciplinary action in any
			 jurisdiction in which the Pharmacist is authorized to practice;
(b) An acknowledgement that the pharmacist
			 must provide services only within the scope of practice of pharmacy and will
			 provide services pursuant to the scope of practice of this state or the health
			 care practitioner's licensing agency, whichever is more restrictive;
(c) An attestation that the pharmacist will
			 not receive compensation for practice in this state;
(d) The name and contact information of the
			 coordinating organization or other entity through which the Pharmacist will
			 practice; and
(e) The dates on
			 which the pharmacist will practice in this state.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0070 - Notification: Nuclear Pharmacists

Current through Register Vol. 63, No. 7, July 1, 2024
In order to qualify under these rules as a nuclear Pharmacist,
				a Pharmacist must:
(1) Meet minimum
			 standards of training and experience in the handling of radioactive materials
			 in accordance with the requirements of the Radiation Protection Services of the
			 Department of Human Services; and
(2) Be a Pharmacist licensed to practice in
			 Oregon; and
(3) Submit to the Board
			 of Pharmacy either:
(a) Evidence of current
			 certification in nuclear pharmacy by the Board of Pharmacy Specialties;
			 or
(b) Evidence that they meet both
			 the following:
(A) Certification of a minimum
			 of six-months on-the-job training under the supervision of a qualified nuclear
			 Pharmacist in a nuclear pharmacy providing radiopharmaceutical services;
			 and
(B) Certification of completion
			 of a nuclear pharmacy training program in a college of pharmacy or a nuclear
			 pharmacy training program approved by the board.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0105 - Responsibilities: General

Current through Register Vol. 63, No. 7, July 1, 2024
When practicing pharmacy per ORS 689, each Pharmacist
				must:
(1) Use that degree of care,
			 skill, diligence and reasonable professional judgment that is exercised by a
			 careful and prudent Pharmacist in the same or similar circumstances;
(2) Be responsible for their own actions,
			 however, this does not absolve the pharmacy from responsibility for the
			 Pharmacist's actions;
(3) Be
			 responsible for the actions of each Intern, Certified Oregon Pharmacy
			 Technician, Pharmacy Technician and nonlicensed pharmacy personnel under their
			 supervision;
(4) Ensure compliance
			 with all state and federal laws and rules governing the practice of
			 pharmacy;
(5) Control each aspect
			 of the practice of pharmacy;
(6)
			 Perform appropriately the duties of a Pharmacist;
(7) Ensure access to reference material and
			 equipment needed based on the services provided;
(8) Ensure services are provided with
			 required interpretation and translation per ORS
			 689.564;
(9) Ensure services occur in a sanitary,
			 secure and confidential environment;
(10) Be clearly identified as a Pharmacist in
			 all interactions and communications (e.g., nametag, phone interaction, chart
			 notations);
(11) Display in plain
			 sight the Pharmacist license within the pharmacy or place of business to which
			 it applies;
(12) Engage in a
			 continuous quality improvement program; and
(13) Review, adhere to and enforce written
			 policies and procedures. The review must:
(a)
			 Occur prior to engaging in the practice of pharmacy;
(b) Occur with each update; and
(c) Be documented and records retained
			 according to OAR 855-104-0055.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0110 - Responsibilities: Confidentiality

Current through Register Vol. 63, No. 7, July 1, 2024
Each Pharmacist must comply with OAR
				855-104-0015 regarding
				confidentiality.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.155
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0115 - Responsibilities: Duty to Report

Current through Register Vol. 63, No. 7, July 1, 2024
Each Pharmacist must report to the board as required by OAR
				855-104-0010. In addition,
				unless state or federal laws relating to confidentiality or the protection of
				health information prohibit disclosure, a Pharmacist must report to the board
				without undue delay, but within 1 business day of:
(1) Confirmed significant drug loss;
			 or
(2) Any loss related to
			 suspected drug theft of a controlled substance.
Statutory/Other Authority: ORS
				  689.205, ORS
				  689.455
Statutes/Other Implemented: ORS
				  689.455, ORS
				  676.150, ORS
				  689.151, ORS
				  689.155
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0120 - Responsibilities: Personnel

Current through Register Vol. 63, No. 7, July 1, 2024
(1) When practicing
			 pharmacy per ORS 689, each Pharmacist must:
(a) Ensure personnel that require licensure
			 have been granted and maintain licensure with the board;
(b) Ensure licensed personnel work within the
			 duties permitted by their licensure;
(c) Ensure non-Pharmacist personnel only
			 perform duties they are licensed and trained to perform;
(d) Know the identity of each Intern under
			 their supervision, and Certified Oregon Pharmacy Technician and Pharmacy
			 Technician under their supervision, direction and control at all
			 times;
(e) Ensure each Intern only
			 practices pharmacy under the supervision of a Pharmacist as outlined in OAR
			 855-120 including any applicable ratios;
(f) Ensure each Certified Oregon Pharmacy
			 Technician and Pharmacy Technician only assists in the practice of pharmacy
			 under the supervision, direction, and control of a Pharmacist as outlined in
			 OAR 855-125;
(g) Ensure licensed
			 personnel do not engage in prohibited practices as outlined for Interns in OAR
			 855-120-0150 and for Certified
			 Oregon Pharmacy Technicians and Pharmacy Technicians in OAR
			 855-125-0150;
(h) Ensure non-licensed personnel do not
			 practice or assist in the practice of pharmacy;
(i) Ensure initial and ongoing training is
			 completed that is commensurate with the tasks that the Pharmacist and persons
			 under their supervision will perform, prior to the performance of those
			 tasks;
(j) Ensure continued
			 competency in tasks that are performed by the Pharmacist and persons under
			 their supervision; and
(k) Ensure
			 that the supervision of non-Pharmacist personnel does not exceed their capacity
			 to safely supervise based on the workload and services being
			 provided.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0122 - Responsibilities: Supervision

Current through Register Vol. 63, No. 7, July 1, 2024
(1) When
			 supervising a Certified Oregon Pharmacy Technician or Pharmacy Technician, each
			 Pharmacist may supervise as many Certified Oregon Pharmacy Technicians or
			 Pharmacy Technicians as they believe in their reasonable professional judgment
			 is appropriate to promote and protect patient health, safety and
			 welfare.
(2) When supervising an
			 Intern, each Pharmacist may supervise:
(a) No
			 more than four Interns participating in direct patient care
			 activities.
(b) As many Interns as
			 they believe in their reasonable professional judgment is appropriate to
			 promote and protect patient health, safety and welfare for Interns
			 participating in non-direct patient care activities such as informational
			 health fairs that provide general information, but not patient-specific
			 information.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0125 - Responsibilities: Drugs, Records and Security

Current through Register Vol. 63, No. 7, July 1, 2024
When practicing pharmacy per ORS 689, each Pharmacist
				must:
(1) Ensure the security of
			 prescription drugs, pharmacy and patient records including:
(a) Provide adequate safeguards against loss,
			 theft, or diversion; and
(b) Ensure
			 only persons authorized by the Pharmacist access the areas where prescription
			 drugs, pharmacy and patient records are stored by restricting access;
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0130 - Responsibilities: Practicing Pharmacy for a Drug Outlet

Current through Register Vol. 63, No. 7, July 1, 2024
(1) When
			 practicing pharmacy per ORS 689 for a Drug Outlet, each Pharmacist must:
(a) Be responsible for the daily conduct,
			 operation, management and control of the Drug Outlet pharmacy;
(b) Ensure that only a Pharmacist has access
			 to the Drug Outlet pharmacy when the pharmacy is closed, except as permitted in
			 OAR 855-041-6310;
(c) Ensure each prescription contains all the
			 elements required in OAR 855-041 or OAR 855-139;
(d) Ensure the patient record contains the
			 elements required in OAR 855-041 or OAR 855-139;
(e) Ensure prescriptions, prescription
			 refills, and drug orders are dispensed:
(A)
			 Accurately;
(B) To the correct
			 party;
(C) Pursuant to a valid
			 prescription;
(D) Pursuant to a
			 valid patient-practitioner relationship; and
(E) For a legitimate medical
			 purpose;
(f) Ensure the
			 Drug Outlet pharmacy is operated in a professional manner at all
			 times;
(g) Ensure the drug outlet
			 reports data as required by federal and state regulations, including but not
			 limited to:
(A) Prescription Drug Monitoring
			 Program (PDMP) per ORS 413A.890, ORS 413A.895, ORS 413A.896, ORS 413A.898, and
			 OAR 333-023;
(B) Death with Dignity
			 per ORS 127.800, ORS
			 127.805, ORS
			 127.810, ORS
			 127.815, ORS
			 127.820, ORS
			 127.825, ORS
			 127.830, ORS
			 127.835, ORS
			 127.840, ORS
			 127.845, ORS
			 127.850, ORS
			 127.855, ORS
			 127.860, ORS
			 127.865, ORS
			 127.870, ORS
			 127.875, ORS
			 127.880, ORS
			 127.885, ORS
			 127.890, ORS
			 127.892, ORS
			 127.895, ORS
			 127.897, and OAR
			 333-009;
(C) Controlled substances
			 per 21 CFR
			 1301.74 (v. 04/01/2023); and
(D) Listed chemicals per
			 21 CFR
			 1310.05 (v. 04/01/2023); and
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0140 - Drug Utilization Review (DUR)

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A Pharmacist
			 must complete a drug utilization review (DUR) by reviewing the patient record
			 prior to dispensing each prescription drug or device for the purpose of
			 identifying the following:
(a)
			 Over-utilization or under-utilization;
(b) Therapeutic duplication;
(c) Drug-disease contraindications;
(d) Drug-drug interactions;
(e) Incorrect drug dosage or
			 formulation;
(f) Inappropriate
			 duration of treatment;
(g)
			 Drug-allergy interactions; and
(h)
			 Drug abuse or misuse.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0145 - Counseling

Current through Register Vol. 63, No. 7, July 1, 2024
(1) For each
			 prescription, the pharmacist must determine the manner and amount of counseling
			 that is reasonable and necessary under the circumstance to promote safe and
			 effective use or administration of the drug or device, and to facilitate an
			 appropriate therapeutic outcome for that patient.
(2) Counseling must be provided or offered to
			 be provided to the patient or patient's agent on the use of a drug or device:
(a) When the drug or device has not been
			 previously dispensed to the patient by the Drug Outlet pharmacy;
(b) When there has been a change in the dose,
			 formulation, or directions;
(c)
			 When the prescription has been transferred to the Drug Outlet pharmacy by oral,
			 written or electronic means; or
(d)
			 For any refill that the pharmacist deems counseling is necessary.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0150 - Prohibited Practices

Current through Register Vol. 63, No. 7, July 1, 2024
Pharmacists must not:
(1) Engage in the dispensing, distribution or
			 delivery of drugs unless working for a registered Drug Outlet
			 pharmacy.
(2) Possess personally or
			 store drugs other than in a registered Drug Outlet pharmacy except for those
			 drugs legally prescribed for the personal use of the Pharmacist or when the
			 Pharmacist possesses or stores the drugs in the usual course of business and
			 within the Pharmacist's scope of practice.
(3) Engage in any form of discrimination,
			 harassment, intimidation, or assault.
(4) Permit any Intern, Certified Oregon
			 Pharmacy Technician or Pharmacy Technician to perform any task in which the
			 supervising Pharmacist is not trained or qualified to perform.
(5) Permit any non-licensed pharmacy
			 personnel to perform any function that constitutes the practice of pharmacy as
			 defined in ORS 689 or the assistance of the practice of pharmacy. Non-licensed
			 personnel may only perform functions permitted by the Pharmacist providing
			 supervision.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.155
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0205 - Pharmacist-in-Charge: Qualifications and Limitations

Current through Register Vol. 63, No. 7, July 1, 2024
(1) In order to be
			 a Pharmacist-in-Charge (PIC), a Pharmacist must have:
(a) Completed at least one year of pharmacy
			 practice; or
(b) Completed a board
			 provided PIC training course either before the appointment or within 90 days
			 after the appointment; and
(c) Be
			 employed by the outlet.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0210 - Pharmacist-in-Charge: Responsibilities

Current through Register Vol. 63, No. 7, July 1, 2024
(1) In addition to
			 the responsibilities of a Pharmacist outlined in OAR 855-115, a
			 Pharmacist-in-Charge of a Drug Outlet pharmacy must:
(a) Be actively engaged in pharmacy
			 activities at the Drug Outlet pharmacy;
(b) Be physically present at the Drug Outlet
			 pharmacy on a regular basis for a sufficient amount of time as needed to ensure
			 Drug Outlet pharmacy compliance;
(c) Be responsible for the ongoing conduct,
			 operation, management and control of the Drug Outlet pharmacy;
(d) Establish, maintain, and enforce written
			 policies and procedures governing the practice of pharmacy that are compliant
			 with federal and state laws and rules;
(e) Ensure maintenance of complete and
			 accurate records;
(f) Establish,
			 maintain and enforce a continuous quality improvement program;
(g) Develop, implement and submit a plan of
			 correction for observations noted on an inspection within the time allowed by
			 the board;
(h) Complete an annual
			 self-inspection of the pharmacy using the Self-Inspection Form provided by the
			 board, by July 1 each year and within 15 days of becoming PIC. The completed
			 self-inspection forms must be signed and dated by the PIC and retained for
			 three years from the date of completion; and
(i) Ensure a controlled substance inventory
			 with discrepancy reconciliation is accurately completed and documented:
(A) For all controlled drugs either prior to
			 the opening or after the close of business on the inventory date:
(i) Within 15 days of a change in PIC;
			 and
(ii) At least every 367 days;
			 and
(B) For all Schedule
			 II controlled drugs:
(i) At least every 93
			 days in a Retail Drug Outlet Pharmacy; and
(ii) At least every 31 days in an
			 Institutional Drug Outlet Pharmacy.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0300 - Services: Consulting Practice

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A Pharmacist
			 who provides services to an Oregon licensed healthcare facility must perform
			 all duties and functions required by the healthcare facility's licensure as
			 well as by any relevant federal and state laws and rules.
(2) A Pharmacist who provides services to a
			 correctional facility, long term care facility, community-based care facility,
			 hospital drug room, or charitable pharmacy that does not have additional
			 Pharmacist service requirements under the terms of its licensure with any other
			 state agency, must provide services that include but are not limited to the
			 following:
(a) Provide the facility with
			 policies and procedures relating to security, storage and distribution of drugs
			 within the facility;
(b) Provide
			 guidance on the proper documentation of drug administration or dispensing;
			 and
(c) Provide educational
			 materials or programs as requested.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0305 - Services: Administration of Vaccines, Drugs, or Devices

Current through Register Vol. 63, No. 7, July 1, 2024
(1) In accordance with ORS
			 689.645 and ORS
			 689.655, a Pharmacist may
			 administer a vaccine, drug or device as specified in this rule. The Pharmacist
			 must be acting:
(a) Under the direction of or
			 pursuant to a lawful prescription or order issued by a licensed practitioner
			 acting within the scope of the practitioner's practice; or
(b) In accordance with a statewide drug
			 therapy management protocol per OAR
			 855-115-0345; or
(c) In accordance with a clinical pharmacy
			 agreement or collaborative drug therapy management agreement per OAR
			 855-115-0315.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0310 - Services: Laboratory

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A Pharmacist
			 must only order and receive laboratory test when:
(a) Managing drug therapy pursuant to the
			 terms of a clinical pharmacy agreement or collaborative drug therapy management
			 agreement with a provider under OAR
			 855-115-0315;
(b) Providing patient care services pursuant
			 to the terms of the post diagnostic formulary listed in OAR
			 855-115-0340 that is developed
			 under ORS 689.645 and adopted by the board
			 under ORS 689.649;
(c) Providing patient care services pursuant
			 to and as allowed by the terms of a protocol listed in OAR
			 855-115-0345 that is developed
			 under ORS 689.645 and adopted by the board
			 under ORS 689.649;
(d) Permitted under a Health Screen Testing
			 Permit pursuant to ORS
			 438.010(8); ORS
			 438.060; ORS
			 438.130(2); ORS
			 438.150(5), (6) and
			 (7); OAR333-024-0370,
			 OAR333-024-0375, OAR333-024-0380, OAR333-024-0385, OAR333-024-0390, OAR333-024-0395 and
			 OAR333-024-0400; or
(e) Monitoring a therapeutic response or
			 adverse effect to drug therapy under ORS
			 689.005.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0315 - Collaborative Drug Therapy Management

Current through Register Vol. 63, No. 7, July 1, 2024
(1) As used in this rule "Collaborative Drug
			 Therapy Management" (CDTM) means the participation by a practitioner and a
			 pharmacist in the management of drug therapy pursuant to a written agreement
			 that includes information on the dosage, frequency, duration and route of
			 administration of the drug, authorized by a practitioner and initiated upon a
			 prescription order for an individual patient and:
(a) Is agreed to by one practitioner and one
			 pharmacist; or
(b) Is agreed to by
			 one or more practitioners in a single organized medical group, such as a
			 hospital medical staff, clinic or group practice, including but not limited to
			 organized medical groups using a pharmacy and therapeutics committee, and one
			 or more pharmacists.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0320 - Services: Medication Therapy Management

Current through Register Vol. 63, No. 7, July 1, 2024
(1) Medication
			 Therapy Management (MTM) is a distinct service or group of services that is
			 intended to optimize the therapeutic outcomes of a patient. Medication Therapy
			 Management can be an independent service provided by a Pharmacist or can be in
			 conjunction with the provision of a medication product with the objectives of:
(a) Enhancing appropriate medication
			 use;
(b) Improving medication
			 adherence;
(c) Increasing detection
			 of adverse drug events;
(d)
			 Improving collaboration between practitioner and Pharmacist; and
(e) Improving outcomes.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0330 - Services: Prescribing - Formulary or Protocol Compendia

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A Pharmacist
			 located and licensed in Oregon may prescribe and dispense a FDA-approved drug
			 and device included on either the Formulary or Protocol Compendia, set forth in
			 this Division.
(2) A Pharmacist may
			 submit a concept, on a form prescribed by the board to the Public Health and
			 Pharmacy Formulary Advisory Committee for consideration, for the addition of a
			 drug or device to the Formulary Compendia or the development of a protocol for
			 the Protocol Compendia. A Pharmacist may provide feedback on the Formulary or
			 Protocol Compendia on a board prescribed form and located on the board
			 website.
(3) A Pharmacist must only
			 prescribe a drug or device consistent with the parameters of the Formulary and
			 Protocol Compendia, and in accordance with federal and state
			 regulations.
(4) The Pharmacist is
			 responsible for recognizing limits of knowledge and experience and for
			 resolving situations beyond their expertise by consulting with or referring
			 patients to another health care provider.
(5) For each drug or device the Pharmacist
			 prescribes via the Formulary or Protocol Compendia, the Pharmacist must:
(a) Ensure training and education
			 requirements have been met prior to engaging in prescribing activities. A copy
			 of all required training and education must be retained according to OAR
			 855-104-0055;
(b) Collect subjective and objective
			 information about the patient's health history and clinical status. If
			 prescribing pursuant to the Formulary Compendia in OAR
			 855-115-0340, a diagnosis from
			 the patient's healthcare provider is required.
(c) Assess the information collected in (b).
			 Any physical assessment must be performed in a face-to-face, in-person
			 interaction and not through electronic means.
(d) Create an individualized patient-centered
			 care plan that utilizes information obtained in the assessment to evaluate and
			 develop a care plan;
(e) Implement
			 the care plan, to include:
(A) Addressing
			 medication and health-related problems and engaging in preventive care
			 strategies;
(B) Initiating,
			 modifying, discontinuing, or administering medication therapy as permitted by
			 the Formulary or Protocol Compendia;
(C) Providing education and self-management
			 training to the patient or caregiver;
(D) Contributing to coordination of care,
			 including the referral or transition of the patient to another health care
			 professional; and
(E) Scheduling
			 follow-up care as needed to achieve goals of therapy.
(f) Monitor and evaluate the effectiveness of
			 the care plan and make modifications to the plan; and
(g) Provide notification to the patient's
			 identified primary care provider or other care providers when applicable within
			 five business days following the prescribing of a Formulary or Protocol
			 Compendia drug or device.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0335 - Services: Prescribing - Prohibited Practices

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A Pharmacist
			 must not prescribe a drug or device via the Formulary or Protocol Compendia:
(a) To self; or
(b) When the compendia requires referral to
			 non-Pharmacist provider.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0340 - Services: Prescribing - Formulary Compendium

Current through Register Vol. 63, No. 7, July 1, 2024
A Pharmacist may prescribe, according to OAR
				855-115-0330 and OAR
				855-115-0335, a FDA-approved
				drug and device listed in the following compendium, pursuant to a diagnosis by
				a health care practitioner who has prescriptive authority and who is qualified
				to make the diagnosis. The diagnosis must be documented. Devices and
				supplies:
(1) Diabetic blood sugar
			 testing supplies;
(2) Injection
			 supplies;
(3) Nebulizers and
			 associated supplies;
(4) Inhalation
			 spacers;
(5) Peak flow
			 meters;
(6) International
			 Normalized Ratio (INR) testing supplies;
(7) Enteral nutrition supplies;
(8) Ostomy products and supplies;
			 and
(9) Non-invasive blood pressure
			 monitors; and
(10) Continuous
			 glucose monitors and associated supplies.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.645 & ORS
				  689.649
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0345 - Services: Prescribing - Protocol Compendium

Current through Register Vol. 63, No. 7, July 1, 2024
A Pharmacist may prescribe, according to OAR
				855-115-0330 and OAR
				855-115-0335, FDA-approved drugs
				and devices listed in the following compendium, pursuant to a statewide drug
				therapy management protocol.
(1)
			 Continuation of therapy including emergency refills of insulin (v.
			 06/2023)
(2) Conditions
(a) Cough and cold symptom management
(A) Pseudoephedrine (v. 06/2021);
(B) Benzonatate (v. 06/2021);
(C) Short-acting beta agonists (v.
			 06/2021);
(D) Intranasal
			 corticosteroids (v. 06/2021);
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0345 - Services: Prescribing - Protocol Compendium

Current through Register Vol. 63, No. 7, July 1, 2024
A Pharmacist may prescribe, according to OAR
				855-115-0330 and OAR
				855-115-0335, FDA-approved drugs
				and devices listed in the following compendium, pursuant to a statewide drug
				therapy management protocol.
(1)
			 Continuation of therapy including emergency refills of insulin (v.
			 06/2024)
(2) Conditions
(a) Cough and cold symptom management
(A) Benzonatate (v. 06/2021);
(B) Short-acting beta agonists (v.
			 06/2021);
(C) Intranasal
			 corticosteroids (v. 06/2021);
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 115 - PHARMACISTS › Section 855-115-0350 - Services: Prescribing Practices - Short-acting Opioid Antagonists

Current through Register Vol. 63, No. 7, July 1, 2024
(1) A Pharmacist may prescribe any FDA
			 approved short-acting opioid antagonist (e.g., naloxone, nalmefene) and the
			 necessary medical supplies to administer a short-acting opioid antagonist for
			 opiate overdose:
(a) When dispensing any
			 opiate or opioid prescription in excess of 50 morphine milligram equivalents
			 (MME);
(b) To an individual seeking
			 a short-acting opioid antagonist;
(c) To an entity seeking a short-acting
			 opioid antagonist.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 120 - INTERNS AND PRECEPTORS › Section 855-120-0001 - Applicability

Current through Register Vol. 63, No. 7, July 1, 2024
This Division applies to any individual who is:
(1) Enrolled in or has completed a Bachelor
			 or Doctor of Pharmacy at a College of Pharmacy or School of Pharmacy (COP or
			 SOP) or is certified by the Foreign Pharmacy Graduate Examination Committee
			 (FPGEC), and who acts as Intern; or
(2) Licensed by the board as a Preceptor to
			 supervise an Intern.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.225
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 120 - INTERNS AND PRECEPTORS › Section 855-120-0005 - Definitions

Current through Register Vol. 63, No. 7, July 1, 2024
(1) "ACPE accredited" means a college or
			 school of pharmacy that is accredited, accredited with probation, pre-candidate
			 or candidate status by Accreditation Council for Pharmacy Education (v.
			 04/02/2024) including the Lebanese American University school in Byblos,
			 Lebanon after 2002.
(2) "College of
			 Pharmacy or School of Pharmacy (COP or SOP)" means an ACPE accredited college
			 or school of pharmacy.
(3)
			 "Healthcare Preceptor" means a pharmacist, or person with an active healthcare
			 license in good standing that can independently practice pharmacy within the
			 scope of their licensure and is licensed by the board to supervise the
			 internship training of a licensed Intern.
(4) "Intern" means a person who is enrolled
			 in or has completed a course of study at a board approved college or school of
			 pharmacy and who is licensed with the board as an Intern.
(5) "Internship Program" means a professional
			 experiential program that is approved by the board.
(6) "Internship Program Supervisor" is a
			 Pharmacist licensed with the board as a Preceptor who supervises the Internship
			 Program for a COP or SOP located in Oregon.
(7) "Other Preceptor" means a person who is
			 not licensed as a pharmacist or other healthcare provider in Oregon and is
			 licensed by the board to supervise the internship training of a licensed
			 Intern.
(8) "Preceptor" means a
			 Pharmacist or a person licensed by the board to supervise the internship
			 training of a licensed Intern.
Publications: Publications referenced are available for
				  review at the agency.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.151 & ORS
				  689.155
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 120 - INTERNS AND PRECEPTORS › Section 855-120-0010 - Licensure: Qualifications - Intern

Current through Register Vol. 63, No. 7, July 1, 2024
(1) To qualify for
			 licensure as an Intern, an applicant must provide proof that they:
(a) Are enrolled in a Doctor of Pharmacy
			 program at a COP or SOP; or
(b)
			 Have graduated with a Bachelor or Doctor of Pharmacy degree from a COP or SOP
			 for the purpose of obtaining the qualifications to apply for a Pharmacist
			 license; or
(c) Have graduated with
			 a Bachelor, Master or Doctor of Pharmacy degree from a foreign college or
			 school of pharmacy and are:
(A) Pursuing an
			 Intern license for the purpose of obtaining the qualifications to apply for a
			 Pharmacist license; and
(B)
			 Certified by the Foreign Pharmacy Graduate Examination Committee (FPGEC).
			 Graduates between 1993 and June 30, 2004 of a Canadian Council for
			 Accreditation of Pharmacy Programs (CCAPP) accredited pharmacy program located
			 in Canada or its jurisdiction with a curriculum taught in English do not have
			 to submit certification from the FPGEC but must meet all other requirements
			 under this rule for an FPGEC certified intern.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 120 - INTERNS AND PRECEPTORS › Section 855-120-0030 - Licensure: Application - Intern

Current through Register Vol. 63, No. 7, July 1, 2024
(1)
			 An application for licensure as an Intern may be accessed on the board
			 website.
(2) The board may issue a
			 license to a qualified applicant after the receipt of:
(a) Documentation required in OAR
			 855-120-0030 and for FPGEC
			 certified documentation required in OAR
			 855-115-0015; and
(b) A completed application including:
(A) Payment of the fee prescribed in OAR
			 855-110;
(B) A current, passport
			 regulation size photograph (full front, head to shoulders);
(C) Personal identification or proof of
			 identity;
(D) A completed national
			 fingerprint-based background check; and
(E) A completed moral turpitude statement or
			 a written description and documentation regarding all conduct that is required
			 to be disclosed.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 120 - INTERNS AND PRECEPTORS › Section 855-120-0035 - Licensure: Renewal or Reinstatement - Intern

Current through Register Vol. 63, No. 7, July 1, 2024
(1) When applying for renewal of an Intern
			 license, an applicant must:
(a) Pay the
			 biennial license fee required in OAR 855-110;
(b) Complete the continuing pharmacy
			 education requirements as directed in OAR 855-135;
(c) Be subject to a criminal background
			 check; and
(d) Provide a written
			 description and documentation regarding all conduct that is required to be
			 disclosed.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 120 - INTERNS AND PRECEPTORS › Section 855-120-0040 - Licensure: Lapse - Intern

Current through Register Vol. 63, No. 7, July 1, 2024
(1) An Intern may
			 let their license lapse by failing to renew or request that the board accept
			 the lapse of their license prior to the expiration date:
(a) Lapse of a license is not
			 discipline.
(b) The board has
			 jurisdiction to proceed with any investigation or any action or disciplinary
			 proceeding against the licensee.
(c) A person may not practice as an Intern if
			 the license is lapsed.
(d) A person
			 may apply for renewal according to OAR
			 855-120-0035.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 120 - INTERNS AND PRECEPTORS › Section 855-120-0050 - Licensure: Voluntary Surrender - Intern

Current through Register Vol. 63, No. 7, July 1, 2024
An Intern may request that the board accept the voluntary
				surrender of their license.
(1) A
			 voluntary surrender of a license is discipline.
(2) The license remains in effect until the
			 board accepts the surrender.
(3) If
			 the board accepts a request for voluntary surrender, the board will issue a
			 final order terminating the license, signed by the licensee and a board
			 representative. The termination date is the date is signed by all parties and
			 served on the licensee.
(4) The
			 licensee must cease practicing as an Intern from the date the license
			 terminates.
(5) A voluntarily
			 surrendered license may not be renewed. A former licensee who wants to obtain a
			 license must apply for a license per OAR
			 855-120-0030 unless the final
			 order prohibits the licensee from doing so.
(6) The board has jurisdiction to proceed
			 with any investigation or any action or disciplinary proceeding against the
			 licensee.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  689.153
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 120 - INTERNS AND PRECEPTORS › Section 855-120-0105 - Responsibilities: General - Intern

Current through Register Vol. 63, No. 7, July 1, 2024
(1) Each Intern is
			 responsible for their own actions; however, this does not absolve the
			 supervising Pharmacist or Preceptor and the pharmacy from responsibility for
			 the Intern's actions.
(2) An Intern
			 is responsible for recognizing the limits of their knowledge and experience and
			 for resolving situations beyond their expertise by consulting with the
			 supervising Pharmacist or Preceptor.
(3) An Intern must:
(a) Comply with all state and federal laws
			 and rules governing the practice of pharmacy;
(b) Only engage in the practice of pharmacy
			 under the supervision of a Pharmacist or Healthcare Preceptor:
(A) After successful completion of academic
			 coursework corresponding to those tasks; and
(B) When permitted by the supervising
			 Pharmacist or Healthcare Preceptor;
(c) Only work within the scope of duties
			 permitted by their license and by the supervising Pharmacist or Healthcare
			 Preceptor;
(d) Know the identity of
			 the supervising Pharmacist or Preceptor at all times;
(e) Only perform tasks they are trained and
			 competent to perform;
(f)
			 Appropriately perform the tasks permitted;
(g) Only access the pharmacy area when a
			 Pharmacist is physically present;
(h) Be clearly identified as an Intern in all
			 interactions and communications (e.g., nametag, phone interaction, chart
			 notations);
(i) Display in plain
			 sight the Intern license within the pharmacy or place of business to which it
			 applies;
(j) Review and adhere to
			 written policies and procedures. The review must:
(A) Occur prior to engaging in the practice
			 of pharmacy as an Intern;
(B) Occur
			 with each update to the policies and procedures; and
(C) Be documented and records retained
			 according to OAR 855-104-0055;
(k) Dispense and deliver
			 prescriptions accurately and to the correct party; and
(l) For hours earned in an Internship
			 Program, must verify that their Preceptor is currently licensed with the board
			 as a Preceptor.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 120 - INTERNS AND PRECEPTORS › Section 855-120-0110 - Responsibilities: Confidentiality - Intern

Current through Register Vol. 63, No. 7, July 1, 2024
Each Intern must comply with OAR
				855-104-0015 regarding
				confidentiality.
Statutory/Other Authority: ORS
				  689.205, ORS
				  689.305, ORS
				  689.315
Statutes/Other Implemented: ORS
				  689.155
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 120 - INTERNS AND PRECEPTORS › Section 855-120-0115 - Responsibilities: Duty to Report - Intern

Current through Register Vol. 63, No. 7, July 1, 2024
Each Intern must report to the board as required by OAR
				855-104-0010. In addition,
				unless state or federal laws relating to confidentiality or the protection of
				health information prohibit disclosure, each Intern must report to the board
				without undue delay, but within 10 working days if they:
(1) Have been removed from an Internship
			 Program site for reasons including but not limited to patient safety,
			 unprofessional conduct or suspected violation of ORS 475, ORS 689 or OAR 855;
			 or
(2) Have been dismissed from the
			 Doctor of Pharmacy degree program.
(3) For (1) and (2) the Intern must report
			 the date and reason for the removal or dismissal.
Statutory/Other Authority: ORS
				  689.205
Statutes/Other Implemented: ORS
				  676.150, ORS
				  689.151, ORS
				  689.155, ORS
				  689.455
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 120 - INTERNS AND PRECEPTORS › Section 855-120-0135 - Responsibilities: Permitted Practices - Intern

Current through Register Vol. 63, No. 7, July 1, 2024
Interns must only practice pharmacy as authorized by the rules
				of the board and as permitted by the supervising Pharmacist or Healthcare
				Preceptor with the practice of pharmacy in their scope. When practicing
				pharmacy, an Intern must adhere to all the applicable rules in OAR 855-115 for
				Pharmacists.
Statutory/Other Authority: ORS
				  689.205, 2022 HB 4034
Statutes/Other Implemented: ORS
				  689.155, 2022 HB
				  4034
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 120 - INTERNS AND PRECEPTORS › Section 855-120-0150 - Prohibited Practices - Intern

Current through Register Vol. 63, No. 7, July 1, 2024
(1) An Intern must
			 not:
(a) Practice pharmacy as defined in ORS
			 689.005 except as permitted by
			 the Pharmacist or Healthcare Preceptor who is supervising the Intern;
(b) Engage in any form of discrimination,
			 harassment, intimidation, or assault in the workplace;
(c) Communicate (e.g., counseling, patient
			 care services, billing) with a patient who prefers to communicate in a language
			 other than English or who communicates in signed language, unless the Intern is
			 a health care interpreter registered by the Oregon Health Authority under ORS
			 413.558 or the supervising
			 Pharmacist or Preceptor is also fluent in the language being interpreted;
			 or
(d) Engage in patient care
			 services when the supervising Pharmacist is not trained and qualified to
			 perform the service.
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 120 - INTERNS AND PRECEPTORS › Section 855-120-0155 - Grounds for Discipline - Intern

Current through Register Vol. 63, No. 7, July 1, 2024
The following are grounds for discipline:
(1) Continuing to practice as an Intern when
			 one of the following has occurred:
(a)
			 Dismissal from the Doctor of Pharmacy degree program enrolled in to obtain the
			 Intern license; or
(b) Failure to
			 maintain an active Intern license; or
Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 120 - INTERNS AND PRECEPTORS › Section 855-120-0190 - Internship Programs

Current through Register Vol. 63, No. 7, July 1, 2024
(1) Interns must
			 complete 1440 hours of internship in an Internship Program to qualify for
			 licensure as a Pharmacist in OAR
			 855-115-0010 and
			 855-115-0015.
(2) For obtaining internship hours necessary
			 to apply for a Pharmacist license, the board approves programs:
(a) Administered by an COP or SOP;
(b) Administered for a foreign graduate with
			 FPGEC certification by a Pharmacist registered with the board as a
			 Preceptor;
(c) Administered by
			 another Board of Pharmacy or equivalent in any US state or
			 jurisdiction.